Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Extracellular vesicles play an important role in intercellular communication, with the potential to serve as biomaterials for nanocarriers. Combining such extracellular vesicles and liposomes results in advanced drug delivery carriers. In this study, we attempted to fabricate hybrid vesicles using a membrane fusion method and incorporated an anticancer drug. As a result, we successfully prepared nanosized uniform hybrid vesicles and evaluated their physicochemical characteristics and intracellular uptake mechanisms via endocytosis in various cell lines. Compared to liposomes, the hybrid vesicles showed better physical properties and a relatively higher reduction in cell viability, which was presumably dependent on the specific cell type. These findings suggest that fusion-based hybrid vesicles offer a novel strategy for delivering therapeutic agents and provide insights into the types of extracellular vesicles that are useful in fabricating hybrid vesicles to develop an advanced drug delivery system.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054022 | PMC |
| http://dx.doi.org/10.3390/pharmaceutics16040440 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Epithelial fusion is mediated by a partial epithelial-mesenchymal transition.
Biol Open
September 2025
National Centre for Biological Sciences, Tata Institute for Fundamental Research, GKVK PO, Bellary Road, Bangalore, 560065, India.
Epithelial fusion is a fundamental morphogenetic process critical for the closure and compartmentalisation of developing organs. While widely studied in systems such as neural tube and palatal closure, the cellular transitions that enable fusion remain poorly understood. Here, we investigate epithelial fusion during chick otic vesicle (OV) closure and identify a transient population of cells at the epithelial interface that mediate this process.
View Article and Find Full Text PDFNanoengineering of Exosomal Surfaces for Precision Targeting and Payload Delivery at the Molecular Level.
Assay Drug Dev Technol
September 2025
School of Applied Sciences, CT University, Sidhwan Khurd, India.
Synergistic nanoplatform of M1 macrophage-derived extracellular vesicles and MoS for tumor-targeted photoimmunotherapy in bladder cancer.
Nanoscale
September 2025
Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Bladder cancer is among the most challenging malignancies, necessitating innovative therapeutic strategies to address tumor recurrence and progression. This study investigates the therapeutic potential of M1 macrophage-derived extracellular vesicles (M1 EVs) engineered with molybdenum disulfide (MoS), forming a hybrid system (M1 EVs@MoS) for combined photothermal and immunotherapy. MoS nanoparticles provide excellent photothermal conversion and photocatalytic efficiency under near-infrared (NIR) irradiation, enabling precise tumor ablation and enhanced reactive oxygen species (ROS) generation.
View Article and Find Full Text PDFAdvances in photodynamic therapy and its combination strategies for breast cancer.
Acta Biomater
August 2025
School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, 2007, Australia; Graduate School of Biomedical Engineering, ARC Centre of Excellence in Nanoscale Biophotonics, Faculty of Engineering, UNSW Sydney, NSW, 2052, Australia. Electronic address:
Breast cancer remains one of the leading causes of cancer-related mortality worldwide, with treatment resistance and recurrence posing significant challenges to conventional therapies such as chemotherapy, surgery, and radiotherapy. Photosensitiser-assisted treatment strategies, particularly photodynamic therapy (PDT), have emerged as a promising alternative for breast cancer due to its targeted nature and minimally invasive approach. This review provides an overview of PDT as a treatment strategy for breast cancer.
View Article and Find Full Text PDFGenetically engineered MSC-derived hybrid cellular vesicles for ROS-scavenging and mitochondrial homeostasis in hepatic ischemia-reperfusion injury.
Mater Today Bio
October 2025
Institute for Engineering Medicine, Kunming Medical University, Kunming, 650500, China.
Hepatic ischemia-reperfusion injury (IRI) poses a significant clinical challenge in liver surgery and transplantation, primarily mediated through oxidative stress, mitochondrial dysfunction, and inflammatory activation. Herein, we developed SOD2-Res@CVs, an engineered vesicular platform combining SOD2-overexpressing mesenchymal stem cell-derived vesicles with liver-targeted and ROS-responsive resveratrol (Res)-loaded liposomes for multi-mechanistic intervention. In vivo imaging demonstrated that SOD2-Res@CVs selectively accumulated in IRI-damaged hepatic tissues.
View Article and Find Full Text PDF